戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 st often (81%) nonshockable (ie, asystole or pulseless electrical activity).
2 electrocardiographic presentations (asystole/pulseless electrical activity).
3 rse than those for patients with asystole or pulseless electrical activity.
4 m survival rates in patients presenting with pulseless electrical activity.
5 rolonged VF typically results in asystole or pulseless electrical activity.
6 ut was offset by more cases with asystole or pulseless electrical activity.
7 entricular fibrillation; and (4) infant with pulseless electrical activity.
8 developed hypotension, dyspnea, hypoxia, and pulseless electrical activity 10 days after resection of
9  (49.84%), ventricular fibrillation (32.0%), pulseless electrical activity (14.6%), and asystole (9.1
10 en groups, as was the incidence of postshock pulseless electrical activity (15/18 MTE, 18/20 BTE) and
11 ar fibrillation/ventricular tachycardia 24%, pulseless electrical activity 16%, asystole 48%, other n
12 ibrillation), ventricular fibrillation (40), pulseless electrical activity (20), and asystole (20), i
13 tricular fibrillation; (2) adult female with pulseless electrical activity; (3) school-aged child wit
14 e nonshockable (83.9%, [asystole = 36.4% and pulseless electrical activity = 47.6%]).
15         The most common initial rhythms were pulseless electrical activity (58.7%) and asystole (33.3
16 .37 [95% CI, 5.70-11.03] minutes; P < .001), pulseless electrical activity (8.22 [95% CI, 5.44-11.00]
17                                 Asystole and pulseless electrical activity account for a high proport
18 atients whose initial rhythm was asystole or pulseless electrical activity, AEDs were associated with
19 suscitation followed by countershock-induced pulseless electrical activity, after which animals were
20 acing) and, after successful defibrillation, pulseless electrical activity and asystole (by high-dose
21 2.2%) had nonshockable rhythms (asystole and pulseless electrical activity) and 2079 (17.8%) had shoc
22 nd separately for nonshockable (asystole and pulseless electrical activity) and shockable (ventricula
23 , 79.3% had an initial rhythm of asystole or pulseless electrical activity, and 20.7% had ventricular
24 manifested ventricular fibrillation (VF), 45 pulseless electrical activity, and 55 asystole as the in
25 tubation, and time to asystole, hypotension, pulseless electrical activity, and declaration of death
26 eased survival after in-hospital asystole or pulseless electrical activity arrest.
27 ng, anaphylaxis with a difficult airway, and pulseless electrical activity arrest.
28 eless ventricular tachycardia, asystole, and pulseless electrical activity, as well as peri-arrest co
29 ardia/ventricular fibrillation as opposed to pulseless electrical activity/asystole (epilepsy, 26%; n
30 al oxygen extraction in adult patients after pulseless electrical activity/asystole or resistant vent
31         A post hoc analysis of patients with pulseless electrical activity at any time during the car
32 after prolonged ventricular fibrillation and pulseless electrical activity cardiac arrest.
33 day after he first became ill, he suffered a pulseless electrical activity cardiorespiratory arrest f
34 nimals developed refractory postcountershock pulseless electrical activity compared with 0 of 16 trea
35     Patients in the subgroup presenting with pulseless electrical activity had intensive care unit ad
36           Asystole occurred in 23 (17 died), pulseless electrical activity in 2, and respiratory arre
37 itial cardiac arrest rhythm was asystole and pulseless electrical activity in 874 children (84.8%) an
38 scitation was used after cardiac arrest with pulseless electrical activity in a patient with recurren
39 ortion of cardiac arrests due to asystole or pulseless electrical activity increased over time (P<0.0
40 ients with nonshockable rhythms (asystole or pulseless electrical activity) is debated.
41 15 defibrillation 1st animals (p <.001), and pulseless electrical activity occurred in only one of 15
42 bserved in patients whose initial rhythm was pulseless electrical activity or asystole.
43     Women are also more likely to present in pulseless electrical activity or systole rather than ven
44 of >4.0 mmol/L (normal range 0.0 to 2.2); c) pulseless electrical activity or ventricular fibrillatio
45 , with an increase in cardiac arrests due to pulseless electrical activity over time (P for trend <0.
46  initial rhythm was perfusing (p < .0001) or pulseless electrical activity (p = .0002), and not relat
47 en the initial cardiac rhythm is asystole or pulseless electrical activity, particularly in patients
48 scitation for the diagnosis and treatment of pulseless electrical activity (PEA) correctly stress the
49 been a significant rise in the prevalence of pulseless electrical activity (PEA).
50 ciated with better outcomes than asystole or pulseless electrical activity (PEA).
51 ock is most commonly followed by asystole or pulseless electrical activity (PEA).
52 to resultant postdefibrillation rhythms (ie, pulseless electrical activity [PEA] or asystole).
53 ith an initial cardiac rhythm of asystole or pulseless electrical activity, pre-hospital cooling usin
54                              In animals with pulseless electrical activity, sodium nitroprusside-enha
55  more asystole (8.8% vs. 7%) and (organized) pulseless electrical activity than men (24% vs. 18%; p <
56 perienced nonshockable OHCA (ie, asystole or pulseless electrical activity) were assessed for eligibi
57  of ventricular tachycardia/fibrillation and pulseless electrical activity, while the comprehensive (